Navigation Links
Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
Date:4/24/2012

PHILADELPHIA, April 24, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters today announced its commitment to support R&D pharmaceutical leaders with a new oncology application for mobile tablet devices, already in use by AstraZeneca executives. The rich visualization dashboard leverages content from Thomson Reuters Cortellis, the company's flagship life sciences platform, and provides real-time data for clinical oncology drug research and development activities.

"Oncology is critical for pharma, as is evidenced by the World Health Organization's projection that an estimated 13.1 million people will die from cancer in 2030, up from the 7.6 million who died in 2008," said Wendy Hamilton, senior vice president at Thomson Reuters.  "The ability of drug companies to quickly find the most relevant research data and clinical information for their oncology studies, in meetings, on the move or at the bench, will allow them to make faster business decisions and focus on areas where there is unmet need."

The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. It is platform independent and accessible via the Internet. Mobile tablet-based devices are the primary method used for accessing the solution.

Users see at-a-glance, side-by-side comparisons of adverse events for drugs already on the market or in clinical trials. They get a deeper understanding of the drugs and how they are being targeted for diseases by segment. The comparisons visualize the level of current research and development activity around an indication, whether by company or mechanism of action, together with information on ongoing clinical trials.

The new applications represent the initial output in an ongoing partnership between Thomson Reuters and AstraZeneca, with other applications due to be released this year. The Thomson Reuters Life Sciences Professional Services team is working on similar innovative projects for other customers too.

Launched in late 2011, Cortellis is the most powerful tool of its kind for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development. For more information on the oncology decision support dashboards and Cortellis, go to http://cortellis.thomsonreuters.com/.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. Thomson Healthcare Cancer Profiler Used in Study
5. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
6. General Practitioners Write Most Prescriptions for Mental Health Drugs, According to Study from Thomson Reuters and SAMHSA
7. University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety
8. Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs
9. The University of Hong Kong Chooses ResearcherID By Thomson Reuters to Standardize Research Identifiers
10. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
11. Americans Losing Confidence in Their Ability to Access and Pay for Healthcare, According to Thomson Reuters Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):